Ventricular Septal Defect Therapeutics Clinical Trials Market Review Report Available at MarketOptimizer.org
Dallas, Texas (PRWEB) October 12, 2014 -- A ventricular septal defect (VSD) is a defect in the ventricular septum, the wall dividing the left and right ventricles of the heart. The ventricular septum consists of an inferior muscular and superior membranous portion and is extensively innervated with conducting cardiomyocytes. The membranous portion, which is close to the atrioventricular node, is most commonly affected in adults and older children in the United States. It is also the type that will most commonly require surgical intervention, comprising over 80% of cases. Membranous ventricular septal defects are more common than muscular ventricular septal defects, and are the most common congenital cardiac anomaly.
Clinical trial report, “Ventricular Septal Defect Global Clinical Trials Review, H2, 2014″ provides data on the Ventricular Septal Defect clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Septal Defect. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ventricular Septal Defect.
Complete report available @ http://www.marketoptimizer.org/ventricular-septal-defect-global-clinical-trials-review-h2-2014.html .
Scope
• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons To Buy
• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Order a Purchase Copy @ http://www.marketoptimizer.org/contacts/purchase?rname=11403 .
Clinical Trial Overview of Top Companies:
• Asklepion Pharmaceuticals, LLC
Clinical Trial Overview of Top Institutes / Government:
• National Heart, Lung, and Blood Institute
• Union Hospital
• Helsinki University Central Hospital
• Aarhus University
• Seoul National University Hospital
• Nationwide Children’s Hospital
• National Taiwan University Hospital
• All India Institute of Medical Sciences
• University of Pennsylvania
• National Center for Research Resources
List of Tables
Ventricular Septal Defect Therapeutics, Global, Clinical Trials by Region, 2014
Ventricular Septal Defect Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Ventricular Septal Defect Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Ventricular Septal Defect Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014
Ventricular Septal Defect Therapeutics Clinical Trials, Europe, Top Countries, 2014
Ventricular Septal Defect Therapeutics Clinical Trials, North America, Top Countries, 2014
Proportion of Ventricular Septal Defect to Cardiovascular Clinical Trials, G7 Countries (%), 2014
Ventricular Septal Defect Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Ventricular Septal Defect Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Ventricular Septal Defect to Cardiovascular Clinical Trials, E7 Countries (%), 2014
Ventricular Septal Defect Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
Ventricular Septal Defect Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014
Ventricular Septal Defect Therapeutics, Global, Clinical Trials by Phase, 2014
Ventricular Septal Defect Therapeutics, Global, Clinical Trials In Progress by Phase 2014
Ventricular Septal Defect Therapeutics, Global, Clinical Trials by Trial Status, 2014
Ventricular Septal Defect Therapeutics Clinical Trials, Global, by End Point Status, 2014
Ventricular Septal Defect Therapeutics, Global, Terminated Clinical Trials, 2014
Ventricular Septal Defect Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Ventricular Septal Defect Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014
Ventricular Septal Defect Therapeutics Clinical Trials, Global, Key Sponsors, 2014
Ventricular Septal Defect Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
Ventricular Septal Defect Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Asklepion Pharmaceuticals, LLC, 2014
Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014
Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Union Hospital, 2014
Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinki University Central Hospital, 2014
Browse more reports on Pharmaceuticals Market @ http://www.marketoptimizer.org/category/life-sciences/pharmaceuticals .
About Us:
MarketOptimizer.org is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Ritesh Tiwari, Market Optimizer, http://www.marketoptimizer.org/, +1 (888) 391-5441, [email protected]
Share this article